Role of miRNAs in Alzheimer’s Disease and Possible Fields of Application
AbstractmiRNAs (or microRNAs) are a class of single-stranded RNA molecules, responsible for post-transcriptional gene silencing through binding to the coding region as well as 3′ and 5′ untranslated region of target genes. About 70% of experimentally detectable miRNAs are expressed in the brain and some studies suggest that miRNAs are intimately involved in synaptic function and in specific signals during memory formation. More and more evidence demonstrates the possible involvement of miRNAs in Alzheimer’s disease (AD). AD is the most common form of senile dementia, a disease that affects memory and cognitive functions. It is a neurodegenerative disorder characterized by loss of synapses, extracellular amyloid plaques composed of the amyloid-β peptide (Aβ), and intracellular aggregates of hyperphosphorylated TAU protein. This review aims to provide an overview of the in vivo studies of the last 5 years in the literature describing the role of the different miRNAs involved in AD. miRNAs hold huge potential as diagnostic and prognostic biomarkers and, at the same time, their modulation could be a potential therapeutic strategy against AD.
Share & Cite This Article
Silvestro, S.; Bramanti, P.; Mazzon, E. Role of miRNAs in Alzheimer’s Disease and Possible Fields of Application. Int. J. Mol. Sci. 2019, 20, 3979.
Silvestro S, Bramanti P, Mazzon E. Role of miRNAs in Alzheimer’s Disease and Possible Fields of Application. International Journal of Molecular Sciences. 2019; 20(16):3979.Chicago/Turabian Style
Silvestro, Serena; Bramanti, Placido; Mazzon, Emanuela. 2019. "Role of miRNAs in Alzheimer’s Disease and Possible Fields of Application." Int. J. Mol. Sci. 20, no. 16: 3979.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.